Sabra Health Care (SBRA) Earnings Analysis

Sabra Health Care (SBRA) next reports earnings on 2026-08-03, consensus EPS 0.1711 USD. Last quarter (2026-04-29) it missed with EPS 0.16 USD vs 0.1667 USD est (-4%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E 34.13.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SBRA next report earnings?

Next earnings date2026-08-03
Consensus EPS estimate0.1711 USD
Revenue estimate0.22B

SBRA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-290.16 USD0.1667 USD-4%Miss
2026-02-120.38 USD0.17 USD+123.5%Beat
2025-08-040.38 USD0.37 USD+2.7%Beat
2025-05-050.37 USD0.36 USD+2.8%Beat
2025-02-190.36 USD0.36 USD0%Beat
2024-10-310.37 USD0.36 USD+2.8%Beat

Beat rate: 5/6 (83%) over reported quarters with consensus data.

SBRA valuation and analyst view

Trailing P/E34.13
Trailing EPS0.61945 USD
Price / book1.99
Dividend yield5.46%
Market cap5.53B
Analyst consensusHold (11 buy / 16 hold / 2 sell)
Avg price target22 USD

Related research pages

Frequently asked questions

When is Sabra Health Care (SBRA)'s next earnings date?

Sabra Health Care is next scheduled to report on 2026-08-03, with a consensus EPS estimate of 0.1711 USD and revenue estimate of 0.22B.

Did SBRA beat earnings last quarter?

In its 2026-04-29 report, SBRA posted EPS of 0.16 USD versus a 0.1667 USD estimate — a miss of 4%.

What is SBRA's earnings track record?

Over the last 6 reported quarters with consensus data, SBRA beat estimates 5 times (83%).

What is SBRA's current P/E ratio and EPS?

SBRA trades at a trailing P/E of 34.13 on trailing EPS of 0.6194496448199837 USD.

What do analysts rate SBRA?

Analyst consensus is "Hold" across 29 ratings (0 strong buy, 11 buy, 16 hold, 2 sell, 0 strong sell). Average 12-month price target: 22 USD.